As the country reopens, the safety of citizens will depend largely on diagnostic devices. Join us to gain insight on UL’s longstanding role in managing regulatory challenges, rapidly bringing safer products to market, and current work to fast-track devices, therapies and other solutions under the emergency access pathways in the US, Europe and other markets.